1 / 4

The Future of Antimicrobial Susceptibility Testing -Rapid Growth and Benefits

Antimicrobial susceptibility testing (AST) is a laboratory procedure to identify the right antimicrobial regimen against microbes. Thus, AST of the causative agent(s) is essential for the timely selection of appropriate antimicrobial therapy. The antimicrobial susceptibility testing market is majorly driven by the high prevalence of infectious diseases, increasing government initiatives and funding towards antimicrobial susceptibility testing programs, technological advancements towards the development of new AST methods, and the emergence of multidrug resistance in microorganisms.

Chaitanya7
Download Presentation

The Future of Antimicrobial Susceptibility Testing -Rapid Growth and Benefits

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ??? ????????? ???????? ?????????????? ????????????????????? ?????? ????????? ??????????? ??????????????? ????????????? ??????? - -???? ???????? ????? ?

  2. Antimicrobial Susceptibility Testing Market – 2021-2028 Meticulous Research®– a leading global market research company published a research report titled “Antimicrobial Susceptibility Testing Market, by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables, Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics), End User (Hospitals, Pharma, Institutes) - Forecast to 2028.” According to this latest publication from Meticulous Research®, the Antimicrobial Susceptibility Testing Market is expected to reach $5.99 billion by 2028, at a CAGR of ~6.4% during the forecast period. Some of the major factors driving the growth of the market include the high prevalence of infectious diseases, development of automated AST products, increasing government initiatives and funding towards antimicrobial susceptibility testing programs, technological advancements towards the development of new AST methods, and the emergence of multidrug resistance in microorganisms. However, stringent government regulations are expected to hinder the growth of this market to a certain extent. Emerging markets and active R&D to develop rapid antimicrobial susceptibility testing are expected to offer significant growth opportunities for players operating in the antimicrobial susceptibility testing market. Download Free Research Sample @ https://www.meticulousresearch.com/download- sample-report/cp_id=5062 Antimicrobial Susceptibility Testing Market: Future Outlook The Antimicrobial Susceptibility Testing Market study presents historical market data in terms of values (2019 and 2020), estimated current data (2021), and forecasts for 2028- by Product (Manual AST Products {Susceptibility Discs, Susceptibility Plates, and MIC Strips}, Consumables, and Automated AST Products), Method (Disk Diffusion, Automated AST, Dilution, and Other Methods), Application (Clinical Diagnostics, Drug Discovery and Development, Other Applications), End User (Diagnostic Laboratories & Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes). The antimicrobial susceptibility testing market study also evaluates industry competitors and analyzes the market at regional and country levels. Based on product, the antimicrobial susceptibility testing market is segmented into manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility testing products, and consumables. In 2021, the manual antimicrobial susceptibility testing products segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The growth in this market is driven by and the low cost of the manual AST products and simple handling procedures. Availability of a diverse range of consumables for manual testing and easy interpretation of tests are further propelling the growth of this segment. Based on method, the disk diffusion segment is expected to account for the largest share of the antimicrobial susceptibility testing market in 2021. The low cost associated with performing AST testing with the disk diffusion method and developments in the disk diffusion method with the use of automated technology is primarily boosting the segment growth. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

  3. Antimicrobial Susceptibility Testing Market – 2021-2028 Based on application, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market in 2021 due to the rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods. Speak to Analysts: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5062 This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the antimicrobial susceptibility testing market in 2021, followed by Europe and Asia-Pacific. Factors driving the North American market include the adoption of technologically advanced susceptibility testing methods and continuous research for new drugs using ASTs, along with the awareness about treatment options. The key players operating in the antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China), among others. Quick Buy –https://www.meticulousresearch.com/Checkout/84907712 Scope of the Report: Antimicrobial Susceptibility Testing Market, by Product •Manual Antimicrobial Susceptibility Testing Products • Consumables •Automated Antimicrobial Susceptibility Testing Products Antimicrobial Susceptibility Testing Market, by Method •Disc Diffusion •Automated AST •Dilution •Other Methods Antimicrobial Susceptibility Testing Market, by Application •Clinical Diagnostics •Drug Discovery and Development •Other Applications Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

  4. Antimicrobial Susceptibility Testing Market – 2021-2028 Antimicrobial Susceptibility Testing Market, by End User •Diagnostic Laboratories and Hospitals •Pharmaceutical and Biotechnology Companies •Research and Academic Institutes Antimicrobial Susceptibility Testing Market, by Geography •North America •Europe •Asia-Pacific (APAC) •Latin America •Middle East & Africa To gain more insights into the market with a detailed table of content and figures: https://www.meticulousresearch.com/product/antimicrobial-susceptibility- testing-market-5062 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com

More Related